- Home
- ICLR vs SOLV Comparison
ICLR vs SOLV Comparison
Compare ICLR & SOLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- SOLV
- Stock Information
- Founded
- ICLR 1990
- SOLV 2023
- Country
- ICLR Ireland
- SOLV United States
- Employees
- ICLR N/A
- SOLV N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- SOLV
- Sector
- ICLR Health Care
- SOLV
- Exchange
- ICLR Nasdaq
- SOLV NYSE
- Market Cap
- ICLR 11.4B
- SOLV 12.7B
- IPO Year
- ICLR 1998
- SOLV N/A
- Fundamental
- Price
- ICLR $146.48
- SOLV $73.58
- Analyst Decision
- ICLR Buy
- SOLV Hold
- Analyst Count
- ICLR 12
- SOLV 10
- Target Price
- ICLR $204.18
- SOLV $80.29
- AVG Volume (30 Days)
- ICLR 1.1M
- SOLV 993.3K
- Earning Date
- ICLR 07-23-2025
- SOLV 08-07-2025
- Dividend Yield
- ICLR N/A
- SOLV N/A
- EPS Growth
- ICLR 11.53
- SOLV N/A
- EPS
- ICLR 9.19
- SOLV 2.18
- Revenue
- ICLR $8,192,621,999.00
- SOLV $8,308,000,000.00
- Revenue This Year
- ICLR N/A
- SOLV $4.11
- Revenue Next Year
- ICLR $2.10
- SOLV N/A
- P/E Ratio
- ICLR $15.62
- SOLV $33.78
- Revenue Growth
- ICLR N/A
- SOLV 1.29
- 52 Week Low
- ICLR $125.10
- SOLV $47.16
- 52 Week High
- ICLR $347.72
- SOLV $85.92
- Technical
- Relative Strength Index (RSI)
- ICLR 58.35
- SOLV N/A
- Support Level
- ICLR $140.20
- SOLV N/A
- Resistance Level
- ICLR $147.26
- SOLV N/A
- Average True Range (ATR)
- ICLR 5.06
- SOLV 0.00
- MACD
- ICLR 1.39
- SOLV 0.00
- Stochastic Oscillator
- ICLR 85.25
- SOLV 0.00
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About SOLV SOLVENTUM CORP
Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.